Biocept Inc (NQ: BIOC )

4.630 USD -0.050 (-1.07%)

Official Closing Price Updated: 5:58 PM EDT, Oct 20, 2020 Add to My Watchlist

Price and Volume

Volume	175,533
Open	4.670
Bid (Size)	4.570 (10)
Ask (Size)	4.650 (5)
Prev. Close	4.680
Today's Range	4.490 - 4.670
52wk Range	0.2100 - 5.130
Shares Outstanding	68,213,349
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Biocept Provides Update on COVID-19 Testing with More than 50,000 Specimens Received

October 06, 2020

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer, announces it has received more than 50,000 COVID-19...

Study Shows Biocept's Target Selector™ May Provide a More Robust Method for Detecting Lung Cancer Metastasis in Cerebrospinal Fluid than Cytology

October 05, 2020

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating cancer patients, announces results from a prospective study comparing its...

Performance

YTD	+1222.86%	+1222.86%
1 Month	-0.86%	-0.86%
3 Month	+557.76%	+557.76%
6 Month	+966.82%	+966.82%
1 Year	+501.30%	+501.30%

More News

Biocept to Present Study Results from Target Selector™ Testing in the Cerebrospinal Fluid of Patients with Lung Cancer at the IASLC Liquid Biopsy Meeting

October 01, 2020

What Are The Best Penny Stocks To Buy Now? 5 Moving Premarket

October 05, 2020

Aegea Biotechnologies, Inc. Announces the Award of Japanese Patent for Primer-Switch Mutation Detection and Amplification Improvement Platform Used to Detect Rare Genetic Alterations and Variants

September 23, 2020

Biocept Announces the Award of Japanese Patent for Primer-Switch Mutation Detection and Amplification Improvement Platform Used to Detect Rare Cell Mutations in Tissue, Blood and Cerebrospinal Fluid

September 23, 2020

Biocept Announces that Highmark Has Made a Positive Coverage Determination on Target Selector™ Liquid Biopsy

September 21, 2020

Biocept Provides COVID-19 Testing Update with More than 35,000 Specimens Received

September 16, 2020

Aegea Biotechnologies, Inc. Advances to Semi-Finals of the $5M XPRIZE Rapid COVID Testing Competition

September 14, 2020

Biocept to Present at the H.C. Wainwright Global Investment Virtual Conference on September 14

September 09, 2020

Stocks That Hit 52-Week Highs On Monday

September 21, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.